drug trial

Pfizer's Potential Arthritis Drug Works in Late-Stage Trial

Pfizer shares were down more than 1% Monday afternoon despite the pharmaceutical giant's report Sunday of successful late-stage trial results for an experimental rheumatoid arthritis drug. The study showed tasocitinib reduced pain and inflammation and improved physical function in patients with moderately to severely active RA.

Roche's Avastin Fails in Early-Stage Colon Cancer Study

Roche's top-selling cancer-fighting drug Avastin has hit another roadblock in testing. In a Phase III study, Avastin failed to improve disease-free survival in early-stage colon cancer patients, the pharmaceutical giant reported.

Biz Brief: Stroke Drug Study Ends Early on Positive Result

Pfizer and Bristol-Myers Squibb said on Thursday that they've decided to halt a clinical trial several months early because data so far suggested the experimental drug apixaban was more effective than aspirin in preventing strokes among patients.